127 related articles for article (PubMed ID: 23158962)
1. Does metabolic syndrome predict significant angiographic coronary artery disease?
Timóteo AT; Mota Carmo M; Cruz Ferreira R
Rev Port Cardiol; 2012 Dec; 31(12):769-78. PubMed ID: 23158962
[TBL] [Abstract][Full Text] [Related]
2. Is metabolic syndrome related with coronary artery disease severity and complexity: An observational study about IDF and AHA/NHLBI metabolic syndrome definitions.
Aykan AÇ; Gül İ; Kalaycıoğlu E; Gökdeniz T; Hatem E; Menteşe Ü; Yıldız BŞ; Yıldız M
Cardiol J; 2014; 21(3):245-51. PubMed ID: 24142676
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and angiographic coronary artery disease prevalence in association with the Framingham risk score.
Konstantinou DM; Chatzizisis YS; Louridas GE; Giannoglou GD
Metab Syndr Relat Disord; 2010 Jun; 8(3):201-8. PubMed ID: 20156070
[TBL] [Abstract][Full Text] [Related]
4. The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome.
Alper AT; Hasdemir H; Sahin S; Ontürk E; Akyol A; Nurkalem Z; Cakmak N; Erdinler I; Gürkan K
Turk Kardiyol Dern Ars; 2008 Sep; 36(6):376-81. PubMed ID: 19155640
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation.
Marroquin OC; Kip KE; Kelley DE; Johnson BD; Shaw LJ; Bairey Merz CN; Sharaf BL; Pepine CJ; Sopko G; Reis SE;
Circulation; 2004 Feb; 109(6):714-21. PubMed ID: 14970105
[TBL] [Abstract][Full Text] [Related]
6. Determining the relationship between metabolic syndrome score and angiographic severity of coronary artery disease.
Yavuz B; Kabakci G; Aksoy H; Tulumen E; Deveci OS; Aytemir K; Tokgozoglu L; Ozkutlu H; Nazli N; Oto A
Int J Clin Pract; 2008 May; 62(5):717-22. PubMed ID: 18266712
[TBL] [Abstract][Full Text] [Related]
7. Effect of Metabolic Syndrome Score, Metabolic Syndrome, and Its Individual Components on the Prevalence and Severity of Angiographic Coronary Artery Disease.
Gui MH; Ling Y; Liu L; Jiang JJ; Li XY; Gao X
Chin Med J (Engl); 2017 Mar; 130(6):669-677. PubMed ID: 28303849
[TBL] [Abstract][Full Text] [Related]
8. The association of plasma homocysteine, coronary risk factors and serum nitrite in patients with coronary artery disease, vascular syndrome x and healthy subjects.
Soysal D; Savaş S; Susam I; Cevik C; Göldeli E; Sözmen E; Güneri S
Anadolu Kardiyol Derg; 2003 Mar; 3(1):26-34, AXVIII-AXIX. PubMed ID: 12626307
[TBL] [Abstract][Full Text] [Related]
9. Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women.
Zornitzki T; Ayzenberg O; Gandelman G; Vered S; Yaskil E; Faraggi D; Caspi A; Goland S; Shvez O; Schattner A; Knobler H
QJM; 2007 Sep; 100(9):575-81. PubMed ID: 17693419
[TBL] [Abstract][Full Text] [Related]
10. Plasma C20-Sphingolipids predict cardiovascular events independently from conventional cardiovascular risk factors in patients undergoing coronary angiography.
Othman A; Saely CH; Muendlein A; Vonbank A; Drexel H; von Eckardstein A; Hornemann T
Atherosclerosis; 2015 May; 240(1):216-21. PubMed ID: 25801014
[TBL] [Abstract][Full Text] [Related]
11. Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?
Anderson JL; Horne BD; Jones HU; Reyna SP; Carlquist JF; Bair TL; Pearson RR; Lappé DL; Muhlestein JB;
Cardiology; 2004; 101(4):185-93. PubMed ID: 14967961
[TBL] [Abstract][Full Text] [Related]
12. Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease.
Verdoia M; Schaffer A; Barbieri L; Di Giovine G; Marino P; Suryapranata H; De Luca G;
Nutr Metab Cardiovasc Dis; 2015 May; 25(5):464-70. PubMed ID: 25791862
[TBL] [Abstract][Full Text] [Related]
13. Elevated fasting blood glucose, but not obesity, is associated with coronary artery disease in patients undergoing elective coronary angiography in a referral hospital in Jordan.
Al-Shudifat AE; Azab M; Johannessen A; Al-Shdaifat A; Agraib LM; Tayyem RF
Ann Saudi Med; 2018; 38(2):111-117. PubMed ID: 29620544
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of metabolic syndrome and diabetes on a high-risk population with suspected coronary artery disease.
Timóteo AT; Mota Carmo M; Cruz Ferreira R
Acta Med Port; 2012; 25(2):83-90. PubMed ID: 22985918
[TBL] [Abstract][Full Text] [Related]
15. [Metabolic syndrome may be better at predicting the prognosis of coronary artery disease than other traditional cardiovascular risk factors].
Hu R; Ma CS; Nie SP; Lü Q; Kang JP; Du X; Liu XH; Chen F; Zhou YJ; Lü SZ
Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(22):1537-41. PubMed ID: 20973234
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical protective effect of central obesity in patients with suspected stable coronary artery disease.
Bechlioulis A; Vakalis K; Naka KK; Bourantas CV; Papamichael ND; Kotsia A; Tzimas T; Pappas K; Katsouras CS; Michalis LK
Obesity (Silver Spring); 2013 Mar; 21(3):E314-21. PubMed ID: 23592684
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2：.
Idilman IS; Akata D; Hazirolan T; Doganay Erdogan B; Aytemir K; Karcaaltincaba M
J Diabetes; 2015 Mar; 7(2):279-86. PubMed ID: 24893617
[TBL] [Abstract][Full Text] [Related]
18. Relationship of visceral fat distribution to angiographically assessed coronary artery disease: results in subjects with or without diabetes or impaired glucose tolerance.
Morricone L; Donati C; Hassan T; Cioffi P; Caviezel F
Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):275-83. PubMed ID: 12616807
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
20. Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography.
Ballestri S; Meschiari E; Baldelli E; Musumeci FE; Romagnoli D; Trenti T; Zennaro RG; Lonardo A; Loria P
Metab Syndr Relat Disord; 2013 Aug; 11(4):289-95. PubMed ID: 23600632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
